Jacobi Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,655
Closed -$293K 1303
2020
Q1
$293K Sell
1,655
-2,058
-55% -$388K 0.06% 216
2019
Q4
$710K Buy
3,713
+7
+0.2% +$1.26K 0.13% 146
2019
Q3
$624K Buy
3,706
+31
+0.8% +$5.05K 0.12% 150
2019
Q2
$615K Buy
3,675
+251
+7% +$34.8K 0.12% 154
2019
Q1
$501K Sell
3,424
-1,902
-36% -$276K 0.13% 117
2018
Q4
$712K Buy
5,326
+2,384
+81% +$391K 0.19% 80
2018
Q3
$560K Buy
2,942
+189
+7% +$34.7K 0.15% 96
2018
Q2
$459K Buy
2,753
+224
+9% +$36K 0.13% 104
2018
Q1
$410K Buy
2,529
+530
+27% +$88.9K 0.12% 104
2017
Q4
$341K Buy
1,999
+1,577
+374% +$283K 0.11% 109
2017
Q3
$86K Sell
422
-50
-11% -$11.6K 0.03% 263
2017
Q2
$114K Hold
472
0.04% 184
2017
Q1
$112K Buy
472
+22
+5% +$5.12K 0.06% 146
2016
Q4
$97K Buy
450
+178
+65% +$36.9K 0.06% 142
2016
Q3
$64K Buy
272
+250
+1,136% +$61.1K 0.03% 206
2016
Q2
$5K Buy
+22
New +$5.07K ﹤0.01% 552

Other funds holding AGN

Jacobi Capital Management's AGN Position: Q2 2020 in Review

Jacobi Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,655 shares — an estimated $293K sold.

Jacobi Capital Management first reported a position in AGN in Q2 2016 and held it in 16 quarters. The position peaked at $712K in Q4 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Jacobi Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Jacobi Capital Management sold 1,655 Allergan plc shares in Q2 2020, an estimated $293K.
  • Jacobi Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 16 quarters.
  • Jacobi Capital Management's Allergan plc position peaked at $712K in Q4 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Jacobi Capital Management's 13F filing for Q2 2020, filed 27 Jul 2020.